1. Increased levels of hypersensitive C-reactive protein was associated with increased risk of non-alcoholic fatty liver disease among non-obese individuals. ...
1. In patients with obesity who had previously undergone a sleeve gastrectomy and are in the early phases of recovery, ...
1. Vascular dementia may be increased by metabolic dysfunction associated steatotic liver disease (MASLD), liver fibrosis, and cirrhosis. Evidence Rating ...
1. Among participants with non-alcoholic fatty liver disease, greater consumption of dietary niacin was associated with a reduction in the ...
1. The risk of cardiovascular disease (CVD) and all-cause death for individuals with type 2 diabetes mellitus (T2DM) is increased ...
1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
1. Patients randomized to have Zinc (Zn) supplementation incorporated into an 8-week diet and exercise intervention for patients with NAFLD ...
1. In this case-control study, younger age of onset of non-alcoholic fatty liver disease (NAFLD) was associated with greater cancer ...
1. In this randomized controlled trial, treatment with pegozafermin improved fibrosis in patients with nonalcoholic steatohepatitis (NASH). 2. Treatment with ...
